Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | SIGHT SCIENCES INC | $15,659,938 | -59.3% | 4,646,866 | -0.1% | 22.25% | -63.1% |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SIGHT SCIENCES INC | $38,511,646 | – | 4,651,165 | – | 60.37% | – | |
| NPCE | New | NEUROPACE INC | $25,238,788 | – | 5,621,111 | – | 39.56% | – |
| New | AILERON THERAPEUTICS INC | $39,990 | – | 22,341 | – | 0.06% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALRN | Exit | AILERON THERAPEUTICS, INC. | $0 | – | -446,817 | – | -0.20% | – |
| NPCE | Exit | NEUROPACE, INC. | $0 | – | -5,621,111 | – | -40.88% | – |
| Exit | SIGHT SCIENCES, INC. | $0 | – | -4,776,232 | – | -58.92% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALRN | Sell | AILERON THERAPEUTICS, INC. | $101,000 | -39.9% | 446,817 | -30.9% | 0.20% | -16.9% |
| IMUX | Exit | IMMUNIC, INC. | $0 | – | -69,704 | – | -0.34% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SIGHT SCIENCES, INC. | $42,938,000 | – | 4,776,232 | – | 60.33% | – | |
| NPCE | New | NEUROPACE, INC. | $27,824,000 | – | 5,621,111 | – | 39.09% | – |
| IMUX | New | IMMUNIC, INC. | $242,000 | – | 69,704 | – | 0.34% | – |
| ALRN | New | AILERON THERAPEUTICS, INC. | $168,000 | – | 646,817 | – | 0.24% | – |